Logo

Ajanta Pharma Share Price

NSE: AJANTPHARM
|
Pharmaceuticals
₹ 3,326.30
-₹19.00 (-0.57%)
1D
Last updated 03 Jul, 2026, 15:54 IST

Ajanta Pharma Share Price Today

As of 5 Jul 2026, Ajanta Pharma share price is ₹3,326.30. The stock opened at ₹3,420.00, compared to its previous close of ₹3,345.30. During today's trading session, Ajanta Pharma share price moved in the range of ₹3,309.10 to ₹3,420.00, with an average price of ₹3,364.55 for the day. Looking at its last 52-week, the stock has touched a low of ₹2,329.90 and a high of ₹3,506.90. On the performance front, Ajanta Pharma share price has increased by 12.79% over the last six months and is up 26.40% on a year-on-year basis.

₹3,309.10
0.57% down today
₹3,420.00
1D LOW
1D HIGH

Ajanta Pharma Returns Calculator

Open
₹3,420.00
High
₹3,420.00
Low
₹3,309.10
Prev. close
₹3,345.30
Circuit
L
H
₹2,661.10
₹3,991.50
52-week
L
H
₹2,329.90
₹3,506.90

Ajanta Pharma Shareholder Returns

Ajanta Pharma Share Price History

Mkt Cap Cr
41,776.00
P/E
33.28
P/B
7.76
ROE
25.39%
D/E
0.01
ROCE
31.81%
Div. Yield
1.00%
EPS(TTM)
75.79
Turnover
1.09
EV/EBITDA
22.53
Net Margin
19.54%
Op. Margin
28.94%
ROA
21.81%
Quick Ratio
2.55
Curr. Ratio
2.50
Based on fundamentals, this stock's
Step 5 of 5
Performance
Excellent
Ajanta Pharma outperforming all market indices
Step 1 of 5
Valuation
Overvalued
Ajanta Pharma appears overvalued compared to its peers
Step 4 of 5
Earnings
Good
Ajanta Pharma revenue, operating profit and net profit are growing
Peer Comparison
Peer comparison — key ratios
NameMkt Cap CrP/EP/BROED/EROCEBook ValueDiv. YieldTurnoverEPS(TTM)
Sun Pharmaceutical Industries4,49,048.0039.025.3713.74%0.6117.33%93.240.85%0.5610.90
Divis Laboratories1,77,179.0069.0010.5715.32%0.0019.56%629.490.45%0.5898.19
Torrent Pharmaceuticals1,57,804.0066.0317.0326.76%1.0518.30%16.900.90%0.4964.75
Cipla1,17,642.0025.472.8711.79%0.0015.66%2.891.06%0.4943.52
Dr. Reddy's Laboratories1,12,368.0027.032.9711.07%0.1812.54%375.780.59%0.6338.68
Zydus Lifesciences1,10,651.0021.604.0818.59%0.3117.35%235.250.09%0.3935.38
Lupin1,09,676.0020.484.8923.76%0.0424.88%659.050.75%0.61129.18
Mankind Pharma1,02,729.0053.006.3011.74%0.3413.13%397.020.04%0.5449.37
Aurobindo Pharma90,608.0025.872.399.25%0.1911.76%391.140.26%0.4841.58
Laurus Labs82,398.9060.2610.1018.21%0.4516.70%10.190.20%0.9713.72

Ajanta Pharma Financials

Full statement

Income Statement · Consolidated

Income Statement · Consolidated — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Revenue₹5,452.86₹4,648.10₹4,208.71₹3,742.64
Other Income₹172.07₹94.50₹84.60₹98.64
Total Revenue₹5,624.93₹4,742.60₹4,293.31₹3,841.28
Total Expenses₹4,247.28₹3,553.44₹3,179.38₹3,096.03
Profit Before Tax₹1,377.65₹1,189.16₹1,113.93₹745.25
Tax₹321.65₹268.77₹297.76₹157.27
Profit After Tax₹1,056.00₹920.39₹816.17₹587.98
EPS - Basic₹84.53₹73.56₹64.82₹45.89
EPS - Diluted₹84.51₹73.53₹64.77₹45.89

Cash Flow · Consolidated

Cash Flow · Consolidated — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Profit before tax₹1,377.65₹1,189.16₹1,113.93₹745.25
Income before WC changes₹1,541.11₹1,301.27₹1,196.96₹876.55
Change in Assets-₹780.61₹31.26-₹230.57-₹3.45
Change in Liabilities₹127.68₹147.67₹130.81₹70.30
Change in WC-₹652.93₹178.93-₹99.76₹66.85
Cash flow from Operations₹529.19₹1,157.23₹785.07₹792.11
Cash flow from Investing-₹428.92-₹376.52₹65.39-₹559.60
Cash flow from Financing-₹167.92-₹733.41-₹1,051.06-₹108.20
Total Cash Flow-₹67.65₹47.30-₹200.60₹124.31
Cash (Start of the year)₹175.12₹129.49₹329.83₹206.36
Cash (End of the year)₹107.47₹176.79₹129.23₹330.67

Balance Sheet · Consolidated

Balance Sheet · Consolidated — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Non-Current Assets₹2,419.41₹2,171.92₹1,907.47₹1,845.02
Current Assets₹3,735.43₹2,843.03₹2,730.92₹2,834.00
Total Assets₹6,154.84₹5,014.95₹4,638.39₹4,679.02
Current Liabilities₹1,415.75₹996.10₹895.76₹1,139.28
Net Current Asset₹2,319.68₹1,846.93₹1,835.16₹1,694.72
Non-Current Liabilities₹212.00₹228.56₹175.27₹151.75
Equity Capital₹4,527.09₹3,790.29₹3,567.36₹3,387.99
Total Equity & Liabilities₹6,154.84₹5,014.95₹4,638.39₹4,679.02

Income Statement · Standalone

Income Statement · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Revenue₹4,845.92₹4,322.04₹3,971.12₹3,411.27
Other Income₹204.40₹119.87₹116.48₹132.75
Total Revenue₹5,050.32₹4,441.91₹4,087.60₹3,544.02
Total Expenses₹3,819.29₹3,261.85₹2,990.65₹2,844.17
Profit Before Tax₹1,231.03₹1,180.06₹1,096.95₹699.85
Tax₹284.21₹263.17₹289.71₹141.13
Profit After Tax₹946.82₹916.89₹807.24₹558.72
EPS - Basic₹75.79₹73.28₹64.11₹43.61
EPS - Diluted₹75.78₹73.25₹64.06₹43.61

Cash Flow · Standalone

Cash Flow · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Profit before tax₹1,231.03₹1,180.06₹1,096.95₹699.85
Income before WC changes₹1,340.16₹1,249.44₹1,146.26₹779.19
Change in Assets-₹319.20-₹42.65-₹261.95₹43.80
Change in Liabilities₹75.93₹128.84₹103.32₹38.86
Change in WC-₹243.27₹86.19-₹158.63₹82.66
Cash flow from Operations₹803.83₹1,053.80₹735.35₹736.29
Cash flow from Investing-₹399.56-₹349.60₹105.02-₹501.31
Cash flow from Financing-₹359.62-₹715.71-₹1,047.70-₹105.12
Total Cash Flow₹44.65-₹11.51-₹207.33₹129.86
Cash (Start of the year)₹48.60₹61.78₹268.85₹139.83
Cash (End of the year)₹93.25₹50.27₹61.52₹269.69

Balance Sheet · Standalone

Balance Sheet · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Non-Current Assets₹2,198.06₹1,978.19₹1,775.77₹1,753.60
Current Assets₹3,118.66₹2,576.06₹2,441.67₹2,551.19
Total Assets₹5,316.72₹4,554.25₹4,217.44₹4,304.79
Current Liabilities₹891.03₹710.72₹629.70₹907.84
Net Current Asset₹2,227.63₹1,865.34₹1,811.97₹1,643.35
Non-Current Liabilities₹202.16₹218.22₹174.17₹150.50
Equity Capital₹4,223.53₹3,625.31₹3,413.57₹3,246.45
Total Equity & Liabilities₹5,316.72₹4,554.25₹4,217.44₹4,304.79
* All values are in INR Crore
Qty
Bid
0
0
0
0
0
0
0
0
0
0
Ask
Qty
0
0
0
0
0
0
0
0
0
0
Bid Total: 0
Ask Total: 0
Buy orders: 0%
Sell orders: 0%
Bearish
1
Neutral
6
Bullish
1
Neutral
by SEBI experts
Expert Pick
EXPPICK
Stop-loss
Entry price
Target
Indicator
Value
Verdict
RSI (14)
62.56
Neutral
ATR (14)
117.28
Neutral
STOCH(9,6)
58.55
Neutral
STOCH RSI (14)
52.47
Neutral
ADX(9)
44.94
Bearish
UO(9)
53.78
Neutral
ROC(12)
8.01
Bullish
WillR(14)
-37.75
Neutral
Period
Simple value
Exponential vaue
5D
3365.2
3327.42
10D
3270.44
3278.03
20D
3165.17
3202.91
50D
3065.97
3091.31
100D
2982.58
2984.67

About Ajanta Pharma

Ajanta Pharma logo
ISIN
INE031B01049
Sector Market Cap
₹ 41,776 Cr

Ajanta Pharma Limited is an India-based specialty pharmaceutical company. It provides a comprehensive range of specialty branded generic products targeting a broad range of chronic and acute therapies. It is focused on branded generic businesses across India, Asia, and Africa. It has a wide range of therapeutic segments, such as cardiology, anti-diabetes, ophthalmology, dermatology, antibiotic, anti-malarial, pain, respiratory, gynecology, pediatric and general health products. Its business also consists of two verticals: the United States generics and the institutional business in Africa. Its ophthalmology products include Bimat (anti glaucoma), Nepaflam (anti-inflammatory), Softdrops (lubricant), and Olopat (anti-allergic). Its cardiology products include MET XL, Atorfit CV, Antihypertensive Cinod, Rosutor Gold, Dapalex and Vilatin. Its subsidiaries include Ajanta Pharma (Mauritius) Limited, Ajanta Pharma USA Inc., Ajanta Pharma Philippines Inc., and Ajanta Pharma Nigeria Limited.

Ajanta Pharma Financial Highlights

  • Revenue: Ajanta Pharma reported revenue of ₹5,624.93 crore in FY26 vs ₹4,742.60 crore in FY25. It showed an increase of 18.60% on a yearly basis.
  • Operating Profit: Ajanta Pharma reported an operating profit of ₹1,377.65 crore in FY26 vs ₹1,189.16 crore in FY25. It showed an increase of 15.85% on a year-on-year basis.
  • Net Profit: Ajanta Pharma reported a net profit of ₹1,056.00 crore in FY26 vs ₹920.39 crore in FY25. It showed an increase of 14.73% on a yearly basis.

Ajanta Pharma Quarterly Result Highlights

  • Ajanta Pharma reported revenue of ₹1,483.07 crore in Mar 2026, compared with ₹1,399.81 crore in Dec 2025, representing an increase of 5.95% on a quarter-on-quarter (QoQ) basis.
  • Ajanta Pharma reported an operating profit of ₹347.11 crore in Mar 2026, compared with ₹358.60 crore in Dec 2025, representing a decrease of 3.20% on a quarter-on-quarter (QoQ) basis.
  • Ajanta Pharma reported a profit of ₹266.70 crore in Mar 2026, compared with ₹273.77 crore in Dec 2025, reflecting a decrease of 2.58% on a QoQ basis.
  • The earnings per share (EPS) of Ajanta Pharma stood at ₹84.53 during Mar 2026.
Know more
Promoters
66.25%
FII
8.26%
Other DII
3.14%
Retail and other
7.12%
Mutual funds
15.22%
Foreign institutions - FII
Compare against other stocks
Ajanta Pharma logo
Ajanta Pharma
Pharmaceuticals
Add Stock
Add Another

FAQs on Ajanta Pharma Share Price